{"id":"https://openalex.org/W3138399121","doi":"https://doi.org/10.1016/j.bcmd.2021.102561","title":"Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease","display_name":"Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease","publication_year":2021,"publication_date":"2021-03-12","ids":{"openalex":"https://openalex.org/W3138399121","doi":"https://doi.org/10.1016/j.bcmd.2021.102561","mag":"3138399121","pmid":"https://pubmed.ncbi.nlm.nih.gov/33744514","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8409227"},"language":"en","primary_location":{"id":"doi:10.1016/j.bcmd.2021.102561","doi":"https://doi.org/10.1016/j.bcmd.2021.102561","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bcmd.2021.102561","pdf_url":null,"source":{"id":"https://openalex.org/S183588319","display_name":"Blood Cells Molecules and Diseases","issn_l":"1079-9796","issn":["1079-9796","1096-0961"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Blood Cells, Molecules, and Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.bcmd.2021.102561","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046490615","display_name":"Betty S. Pace","orcid":"https://orcid.org/0000-0002-1275-4112","observed_orcids":["https://orcid.org/0000-0002-1275-4112"]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Betty S. Pace","raw_affiliation_strings":["Department of Pediatrics, Augusta University, Augusta, GA 30912, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Augusta University, Augusta, GA 30912, USA","institution_ids":["https://openalex.org/I25041050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086539163","display_name":"Susan P. Perrine","orcid":"https://orcid.org/0000-0003-2179-8376","observed_orcids":["https://orcid.org/0000-0003-2179-8376"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I4210145594","display_name":"Phoenicia Biosciences (United States)","ror":"https://ror.org/04fwbrn28","country_code":"US","type":"company","lineage":["https://openalex.org/I4210145594"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Perrine","raw_affiliation_strings":["Phoenicia BioSciences, Weston, MA 02493, USA; Department of Pharmacology and Experimental Therapeutics, Hemoglobinopathy Thalassemia Research Unit, Boston University School of Medicine, Boston, MA 02118, USA","Department of Pharmacology and Experimental Therapeutics, Hemoglobinopathy Thalassemia Research Unit, Boston University School of Medicine, Boston, MA 02118, USA","Phoenicia BioSciences, Weston, MA 02493, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phoenicia BioSciences, Weston, MA 02493, USA; Department of Pharmacology and Experimental Therapeutics, Hemoglobinopathy Thalassemia Research Unit, Boston University School of Medicine, Boston, MA 02118, USA","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I4210145594"]},{"raw_affiliation_string":"Department of Pharmacology and Experimental Therapeutics, Hemoglobinopathy Thalassemia Research Unit, Boston University School of Medicine, Boston, MA 02118, USA","institution_ids":["https://openalex.org/I111088046"]},{"raw_affiliation_string":"Phoenicia BioSciences, Weston, MA 02493, USA","institution_ids":["https://openalex.org/I4210145594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101897218","display_name":"Yaqin Li","orcid":"https://orcid.org/0000-0002-5626-9557","observed_orcids":["https://orcid.org/0000-0002-5626-9557"]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Biaoru Li","raw_affiliation_strings":["Department of Pediatrics, Augusta University, Augusta, GA 30912, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Augusta University, Augusta, GA 30912, USA","institution_ids":["https://openalex.org/I25041050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022759647","display_name":"Levi Makala","orcid":"https://orcid.org/0000-0002-6352-5782","observed_orcids":["https://orcid.org/0000-0002-6352-5782"]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Levi Makala","raw_affiliation_strings":["Department of Pediatrics, Augusta University, Augusta, GA 30912, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Augusta University, Augusta, GA 30912, USA","institution_ids":["https://openalex.org/I25041050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100787086","display_name":"Hongyan Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hongyan Xu","raw_affiliation_strings":["Department of Population Health Sciences, Augusta University, Augusta, GA 30912, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Population Health Sciences, Augusta University, Augusta, GA 30912, USA","institution_ids":["https://openalex.org/I25041050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036516284","display_name":"Mayuko Takezaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mayuko Takezaki","raw_affiliation_strings":["Department of Pediatrics, Augusta University, Augusta, GA 30912, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Augusta University, Augusta, GA 30912, USA","institution_ids":["https://openalex.org/I25041050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109710826","display_name":"Roman F. Wolf","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roman F. Wolf","raw_affiliation_strings":["Department of Comparative Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Comparative Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101522895","display_name":"Amy Wang","orcid":"https://orcid.org/0000-0002-1829-5877","observed_orcids":["https://orcid.org/0000-0002-1829-5877"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Wang","raw_affiliation_strings":["Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102027540","display_name":"Xin Xu","orcid":"https://orcid.org/0000-0003-1163-9304","observed_orcids":["https://orcid.org/0000-0003-1163-9304"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xin Xu","raw_affiliation_strings":["Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Junfeng Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Junfeng Huang","raw_affiliation_strings":["Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004091925","display_name":"Asaf Alimardanov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Asaf Alimardanov","raw_affiliation_strings":["Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070884494","display_name":"Gregory J. Tawa","orcid":"https://orcid.org/0000-0002-5573-308X","observed_orcids":["https://orcid.org/0000-0002-5573-308X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory J. Tawa","raw_affiliation_strings":["Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068018268","display_name":"Jos\u00e9 Sangerman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I4210145594","display_name":"Phoenicia Biosciences (United States)","ror":"https://ror.org/04fwbrn28","country_code":"US","type":"company","lineage":["https://openalex.org/I4210145594"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jose Sangerman","raw_affiliation_strings":["Phoenicia BioSciences, Weston, MA 02493, USA; Department of Pharmacology and Experimental Therapeutics, Hemoglobinopathy Thalassemia Research Unit, Boston University School of Medicine, Boston, MA 02118, USA","Department of Pharmacology and Experimental Therapeutics, Hemoglobinopathy Thalassemia Research Unit, Boston University School of Medicine, Boston, MA 02118, USA","Phoenicia BioSciences, Weston, MA 02493, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phoenicia BioSciences, Weston, MA 02493, USA; Department of Pharmacology and Experimental Therapeutics, Hemoglobinopathy Thalassemia Research Unit, Boston University School of Medicine, Boston, MA 02118, USA","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I4210145594"]},{"raw_affiliation_string":"Department of Pharmacology and Experimental Therapeutics, Hemoglobinopathy Thalassemia Research Unit, Boston University School of Medicine, Boston, MA 02118, USA","institution_ids":["https://openalex.org/I111088046"]},{"raw_affiliation_string":"Phoenicia BioSciences, Weston, MA 02493, USA","institution_ids":["https://openalex.org/I4210145594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051467517","display_name":"Aidan D. Faller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I4210145594","display_name":"Phoenicia Biosciences (United States)","ror":"https://ror.org/04fwbrn28","country_code":"US","type":"company","lineage":["https://openalex.org/I4210145594"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aidan Faller","raw_affiliation_strings":["Phoenicia BioSciences, Weston, MA 02493, USA; Department of Pharmacology and Experimental Therapeutics, Hemoglobinopathy Thalassemia Research Unit, Boston University School of Medicine, Boston, MA 02118, USA","Department of Pharmacology and Experimental Therapeutics, Hemoglobinopathy Thalassemia Research Unit, Boston University School of Medicine, Boston, MA 02118, USA","Phoenicia BioSciences, Weston, MA 02493, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phoenicia BioSciences, Weston, MA 02493, USA; Department of Pharmacology and Experimental Therapeutics, Hemoglobinopathy Thalassemia Research Unit, Boston University School of Medicine, Boston, MA 02118, USA","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I4210145594"]},{"raw_affiliation_string":"Department of Pharmacology and Experimental Therapeutics, Hemoglobinopathy Thalassemia Research Unit, Boston University School of Medicine, Boston, MA 02118, USA","institution_ids":["https://openalex.org/I111088046"]},{"raw_affiliation_string":"Phoenicia BioSciences, Weston, MA 02493, USA","institution_ids":["https://openalex.org/I4210145594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005729398","display_name":"Wei Zheng","orcid":"https://orcid.org/0000-0002-9323-5663","observed_orcids":["https://orcid.org/0000-0002-9323-5663"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei Zheng","raw_affiliation_strings":["Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004495987","display_name":"London Toney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"London Toney","raw_affiliation_strings":["Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022392246","display_name":"Sharie J. Haugabook","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sharie J. Haugabook","raw_affiliation_strings":["Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: sharie.haugabook@nih.gov","Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: sharie.haugabook@nih.gov","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]},{"raw_affiliation_string":"Division of Preclinical Innovation, Therapeutics for Rare and Neglected Diseases (TRND) Program, Therapeutic Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5022392246"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":null,"fwci":2.28,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.88096734,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":98},"biblio":{"volume":"89","issue":null,"first_page":"102561","last_page":"102561"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12094","display_name":"Hemoglobin structure and function","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11660","display_name":"Blood groups and transfusion","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benserazide","display_name":"benserazide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/fetal-hemoglobin-induction","display_name":"fetal hemoglobin induction","score":0.8019999861717224},{"id":"https://openalex.org/keywords/beta-thalassemia","display_name":"beta-thalassemia","score":0.871999979019165},{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":1.0},{"id":"https://openalex.org/keywords/beta-hemoglobinopathies","display_name":"\u03b2-hemoglobinopathies","score":0.9559999704360962},{"id":"https://openalex.org/keywords/enantiomers","display_name":"enantiomers","score":0.7279999852180481},{"id":"https://openalex.org/keywords/racemate","display_name":"racemic mixtures","score":0.7820000052452087},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7099999785423279},{"id":"https://openalex.org/keywords/intermittent-dosing","display_name":"intermittent dosing","score":0.6840000152587891},{"id":"https://openalex.org/keywords/gamma-globin-mrna","display_name":"gamma-globin mRNA","score":0.7429999709129333},{"id":"https://openalex.org/keywords/erythroid-progenitors","display_name":"erythroid progenitor cells","score":0.7519999742507935},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.625}],"concepts":[{"id":"https://openalex.org/C2776317666","wikidata":"https://www.wikidata.org/wiki/Q2496436","display_name":"Fetal hemoglobin","level":4,"score":0.7335389256477356},{"id":"https://openalex.org/C2779668550","wikidata":"https://www.wikidata.org/wiki/Q1642147","display_name":"Hemoglobinopathy","level":3,"score":0.6186000108718872},{"id":"https://openalex.org/C2777799968","wikidata":"https://www.wikidata.org/wiki/Q185137","display_name":"Thalassemia","level":2,"score":0.6035090684890747},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.512950599193573},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5065683126449585},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3703417181968689},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34567689895629883},{"id":"https://openalex.org/C172680121","wikidata":"https://www.wikidata.org/wiki/Q26513","display_name":"Fetus","level":3,"score":0.32061728835105896},{"id":"https://openalex.org/C2776175824","wikidata":"https://www.wikidata.org/wiki/Q1145668","display_name":"Hemolytic anemia","level":2,"score":0.310479998588562},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3077520430088043},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1311013102531433},{"id":"https://openalex.org/C2779234561","wikidata":"https://www.wikidata.org/wiki/Q11995","display_name":"Pregnancy","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000755","descriptor_name":"Anemia, Sickle Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000755","descriptor_name":"Anemia, Sickle Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001545","descriptor_name":"Benserazide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005319","descriptor_name":"Fetal Hemoglobin","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010215","descriptor_name":"Papio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015259","descriptor_name":"Dopamine Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017086","descriptor_name":"beta-Thalassemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017086","descriptor_name":"beta-Thalassemia","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055545","descriptor_name":"gamma-Globins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.bcmd.2021.102561","doi":"https://doi.org/10.1016/j.bcmd.2021.102561","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bcmd.2021.102561","pdf_url":null,"source":{"id":"https://openalex.org/S183588319","display_name":"Blood Cells Molecules and Diseases","issn_l":"1079-9796","issn":["1079-9796","1096-0961"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Blood Cells, Molecules, and Diseases","raw_type":"journal-article"},{"id":"pmid:33744514","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33744514","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood cells, molecules & diseases","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8409227","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8409227","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Blood Cells Mol Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1016/j.bcmd.2021.102561","doi":"https://doi.org/10.1016/j.bcmd.2021.102561","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bcmd.2021.102561","pdf_url":null,"source":{"id":"https://openalex.org/S183588319","display_name":"Blood Cells Molecules and Diseases","issn_l":"1079-9796","issn":["1079-9796","1096-0961"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Blood Cells, Molecules, and Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G386607036","display_name":null,"funder_award_id":"HHSN261200800001E)","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5888954722","display_name":null,"funder_award_id":"HHSN261200800001C","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G6654230387","display_name":"Development of a clinical hemoglobin modulator","funder_award_id":"R42HL110727","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G8936940596","display_name":"Novel Globin Gene Modulators","funder_award_id":"R01DK052962","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G9000903803","display_name":"Repurposing an EU Therapeutic for Hemoglobinopathies","funder_award_id":"ZIATR000010","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320309647","display_name":"School of Medicine, Boston University","ror":"https://ror.org/05qwgg493"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":57,"referenced_works":["https://openalex.org/W178748180","https://openalex.org/W1488281450","https://openalex.org/W1524737400","https://openalex.org/W1538645078","https://openalex.org/W1740485169","https://openalex.org/W1745598831","https://openalex.org/W1832776775","https://openalex.org/W1861971834","https://openalex.org/W1881664604","https://openalex.org/W1967354181","https://openalex.org/W1969338782","https://openalex.org/W1992681592","https://openalex.org/W1995325755","https://openalex.org/W2005752061","https://openalex.org/W2005843872","https://openalex.org/W2008556768","https://openalex.org/W2010407535","https://openalex.org/W2026645409","https://openalex.org/W2032422161","https://openalex.org/W2032966910","https://openalex.org/W2036308544","https://openalex.org/W2046648607","https://openalex.org/W2049584544","https://openalex.org/W2057582400","https://openalex.org/W2064545896","https://openalex.org/W2070879341","https://openalex.org/W2074164679","https://openalex.org/W2077869291","https://openalex.org/W2079358849","https://openalex.org/W2109085547","https://openalex.org/W2117829414","https://openalex.org/W2121759181","https://openalex.org/W2127532651","https://openalex.org/W2142734422","https://openalex.org/W2147182596","https://openalex.org/W2155090266","https://openalex.org/W2155119455","https://openalex.org/W2155829072","https://openalex.org/W2170086069","https://openalex.org/W2182395638","https://openalex.org/W2200510043","https://openalex.org/W2274632826","https://openalex.org/W2313541759","https://openalex.org/W2325016458","https://openalex.org/W2326476344","https://openalex.org/W2334263927","https://openalex.org/W2341415719","https://openalex.org/W2542104306","https://openalex.org/W2559643145","https://openalex.org/W2606784602","https://openalex.org/W2794460338","https://openalex.org/W2883474598","https://openalex.org/W2883955692","https://openalex.org/W2951288545","https://openalex.org/W2960523473","https://openalex.org/W3096874248","https://openalex.org/W4237041690"],"related_works":["https://openalex.org/W3096874248","https://openalex.org/W2901247945","https://openalex.org/W2274632826","https://openalex.org/W7097254922","https://openalex.org/W2026645409","https://openalex.org/W2200510043","https://openalex.org/W3217243785","https://openalex.org/W2113048877","https://openalex.org/W2990698503","https://openalex.org/W3096571578"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-03-29T00:00:00"}